The preclinical evaluation of angiogenesis inhibitors

Investigational New Drugs

Volumn 15, Issue 1, 1997, Pages 5-13

  O'Reilly, Michael S ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Animal models; Carcinoma; Endothelial cells; Inhibitors; Metastasis

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BATIMASTAT; BETA CYCLODEXTRIN; BETA INTERFERON; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON; HEPARIN LYASE; HYDROCORTISONE; INTERLEUKIN 12; MARIMASTAT; OCTREOTIDE; PENTOSAN POLYSULFATE; PLASMINOGEN ACTIVATOR INHIBITOR; PROLACTIN; RETINOID; ROQUINIMEX; SURAMIN; TECOGALAN; THALIDOMIDE; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; CANCER INHIBITION; CLINICAL TRIAL; DRUG SCREENING; HUMAN; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ALLANTOIS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CHORION; CORNEA; DISEASE MODELS, ANIMAL; DRUG EVALUATION; DRUGS, INVESTIGATIONAL; ENDOTHELIUM, VASCULAR; IRIS; MACACA FASCICULARIS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0031001536     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005762410476     Document Type: Review

References (87)

1. Hobson B, Denekamp J: Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br J Cancer 49:405-413, 1984
2. Denekamp J: Vasculature as a target for tumor therapy. In: Hammersen F, Hudlicka O (eds) Progress in Applied Microcirculation. Karger, Basel. 1984. p 28-38
3. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1:27-31, 1995
4. Fidler IJ: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185-188, 1994
5. Liotta LA, Stetler-Stevenson WG, Steeg PS: Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9:543-551, 1991
6. Folkman J: Tumor angiogenesis. In: Mendelsohn J, Israel MA, Liotta LA (eds) The Molecular Basis of Cancer. W.B. Saunders Co. (A Division of Harcourt Brace and Company). Philadelphia, London. 1995. pp 206-232
7. Kandel J, Bossy-Wetzel E, Radvany F, Klagsburn M, Folkman J, Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095-1104, 1991
8. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-153, 1995
9. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994
10. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355, 1989
11. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Nat Acad Sci USA 87:6624-6628, 1990
12. Dameron KM, Volpert OV, Tainsky MA, Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582, 1994
13. Folkman J, Klagsburn M: Angiogenic factors. Science 235:442-147, 1987
14. Folkman, J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992
15. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90:1927-1941, 1993
16. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989
17. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989
18. Moses MA, Klagsburn M, Shing Y: The role of growth factors in vascular cell development and differentiation. Int Rev Cytology 161:1-48, 1995
19. Auerbach W, Auerbach R: Angiogenesis inhibition: a review. Pharmac Ther 63:265-311, 1994
20. Clapp C, Martial JA, Guzman RC, Rentier-Delrue F, Weiner RI: The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299, 1993
21. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77-79, 1990
22. Gupta SK, Hassel T, Singh JP: A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc Natl Acad Sci USA 92:7799-7803, 1995
23. Homandberg GA, Williams JE, Grant DBS, Eisenstein R: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am J Path 120:327-332, 1985
24. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511, 1993
25. 2. Cancer Res 51:903-906, 1991
26. Brooks PC, Rosenfeld M, Reisfeld R, Hu, T, Klier G, Cheresh DA: Integrin α v β3 antagonists promote tumur regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164, 1994
27. Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248:1408-1410, 1990
28. Ingber DE, Folkman J: Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59:453-459, 1988
29. Singh RK, Gutman M, Bucana CD, Sanchez R, LlansaN: Interferon a and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 92:4562-4566, 1995
30. O'Reilly MS, Holmgren L, Chen CC, Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med (in press) 1996
31. Folkman J, Haundenschild CC, Zetter BR: Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76:5217-5221, 1979
32. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M: Heparin-affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223:1296-1299, 1984
33. Folkman J, Haudenschild C: Angiogenesis in vitro. Nature 288:551-556, 1978
34. Pepper MS, Ferrara N, Orci L, Montesano L: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Comm 189:824-831, 1992
35. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD: Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755, 1990
36. Montesano R, Orci L, Vassali P: In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97:1648-1652, 1983
37. Montesano R, Vassali JD, Baird A, Guillemin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301, 1986
38. Ingber DE, Folkman J: Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 109:317-330, 1989
39. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61, 1989
40. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69:508-517, 1993
41. Nicosia RF, Ottinett A: growth of microvessels in serum-free matrix culture of rat aorta - a quantitative assay of angiogenesis in vitro. Lab Invest 63:115-122, 1990
42. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillan parent. Biochem Biophys Res Comm 174:1070-1076, 1991
43. Grant DS, Tashiro K-I, Sequi-Real B, Yamada Y, Martin GR, Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58:933-943, 1989
44. Montesano R: Regulation of angiogenesis in vitro (review). Euro J Clin Invest 22:504-515, 1992
45. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171, 1986
46. Frater-Schroder M, Risau W, Hallmann R, Gautschi P, Bohlen P: Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84:5277-5281, 1987
47. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nusseir N: Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329:630-632, 1987
48. Fajardo LF, H. K., Prionas SD, Allison AC: Dual role of tumor necrosis factor-α in angiogenesis. Amer J Path 140:539-544, 1992
49. Ingber DE, Madri JA, Folkman J: A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119:1768, 1986
50. Crum R, Szabo S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230:1375, 1985
51. Auerbach R, Kubai L, Knighton D, Folkman J: A simple procedure for the long-term cultivation of chicken embryos. Developmental Biol 41:391, 1974
52. Knighton D, Ausprunk D, Tapper D, Folkman J: Avascular and vascular phases of tumour growth in the chick embryo. Brit J Cane 35:347-356, 1977
53. Nguyen M, Shing Y, Folkman J: Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvascular Res 47:31-40, 1994
54. Fajardo LF, Kowalski J, Kwan HH, Prionas SD, Allison AC: The disc angiogenesis system. Lab Invest 58:718-724, 1988
55. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67:519-528, 1992
56. Gimbrone MAJ, Cotran R, Leapman S, Folkman J: Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Canc Inst 52:413-427, 1974
57. Muthukkaruppan V, Auerbach R: Angiogenesis in the mouse cornea. Science 28:1416-1418, 1979
58. Fournier GA, Lutty GA, Watt S, Fenselau A, Patz A: A corneal micropocket assay for angiogenesis in the rat eye. Invest Opthalmol Vis Sci 21:351-354, 1981
59. Kenyon BM, E. Chen CC, Flynn E, Folkman J, D'Amato RJ: A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (in press) 1996
60. Chen C, Parangi S, Tolentino MJ, Folkman J: A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 55:4230-4233, 1995
61. Virdi PS, Hayreh SS: Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. Arch Ophthalmol 100:331-341, 1982
62. Miller JW, Stinson WG, Gregory WA, et al.: Phthalocyanine photodynamic therapy of experimental iris neovascularization. Opthalmology 98:1711-1719, 1991
63. Miller JW, Stinson WG, Folkman J: Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 100:9-14, 1993
64. Miller J, Adamis AP, Shima DT, D'Amore PA, O'Reilly MS, Folkman J, Dvorak H, Brown LF, Berse B, Yeo T-K, Yeo K-T: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Amer J Path 145:574-584, 1994
65. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186, 1971
66. Brem H, Folkman J: Analysis of experimental antiangiogenic therapy. J Pediatr Surg 28:445-451, 1993
67. Brem H, Gresser I, Grosfeld J, Folkman J: The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28:1253-1257, 1993
68. Teicher BA, Sotomayor EA, Huang ZD: Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702-6704, 1992
69. Teicher B, Holden S, Ara G, Northey D: Response of the FSall fibrosarcoma to antiangiogenic modulators plus cytotoxic agents. Anticancer Res 13:2101-2106, 1993
70. Teicher BA, Holden SA, Ara G, Sotomayor EA, Dong HZ: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 57:1-6, 1994
71. Teicher BA, Dupuis N, Kusomoto T, Robinson MF, Liu F, Menon K, Coleman CN: Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy. Radiation One Invest 2:269-276, 1995
72. Hanahan D: Heritable formation of pancreatic beta-cell tumors in transgenic mice harboring recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122, 1985
73. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557, 1990
74. Tamargo RJ, Bok RA, Brem H: Angiogenesis inhibition by minocycline. Cancer Res 51:672-675, 1991
75. Dvorak HF, Gresser I: Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst 81:497-502, 1989
76. Parangi S, O'Reilly M, Christofori G, Holmgren L, Grosfeld J, Folkman J, Hanahan D: Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93:2002-2007, 1996
77. Folkman, J: Clinical applications of angiogenesis research. N Eng J Med 333:1757-1763, 1995
78. Folkman J: Angiogenesis and breast cancer (editorial; comment). J Clin Oncol 12:454-466, 1994
79. D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082-4085, 1994
80. Ezekowitz RAB, Mulliken JB, Folkman J: Interferon alfa-2a therapy For life-threatening hemangiomas of infancy. N Eng Jour Med 326:1456-1463, 1992
81. Williams S: Angiogenesis in three-dimensional cultures (editorial). Lab Investigation 69:491-493, 1993
82. Folkman J: Tumor angiogenesis and tissue factor. Nature Med 2:167-168, 1996
83. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Eng J Med 324: 1-8, 1991
84. Weidner N: Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147:9-19, 1995
85. Watanabe H, Nguyen M, Schizer M, Li V, Hayes DF, Sallan DF: Basic fibroblast growth factor in human serum - a prognostic test for breast cancer. Molecular Biol Cell 3:234a, 1992
86. Nguyen M, Watanabe H, Budson AE, Richie JP, Folkman J: Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst 85:241-242, 1993
87. Folkman J: The vascularization of tumors. Scientific Amer 234:58-73, 1976